Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.6/5
Huadong Medicine Co Ltd A (000963 CH)
Watchlist
54
Analysis
Health Care
•
China
Huadong Medicine Co., Ltd. wholesales and retails medicines, pharmaceutical preparations, biological products, and medical instruments. Through its subsidiaries, the Company also manufactures antibiotic medicines and biochemical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
10 Nov 2020 01:41
China Healthcare Weekly (Nov.6)
This article summarized the new healthcare policy released in China, major industry viewpoints, company news and capital markets review for the...
Xinyao (Criss) Wang
Follow
326 Views
Share
bearish
•
Kweichow Moutai
•
07 Oct 2019 06:43
Shanghai/Shenzhen Connect Ideas: Stalled Flows Ahead of Golden Week (2019-10-04)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
560 Views
Share
bullish
•
Kweichow Moutai
•
23 May 2019 07:55
Shanghai/Shenzhen Connect Ideas: Technologies, Porks and Hard Liquors (2019-05-17)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
697 Views
Share
bullish
•
Sinclair Pharma
•
07 Sep 2018 10:12
Europe M&A: Huadong's Offer for Sinclair Looks a Done Deal
After confirmation of discussions of the merger back in early July, Sinclair Pharma (SPH LN) announced it has entered into an Offer Agreement with...
David Blennerhassett
Follow
488 Views
Share
bullish
•
MSCI Emerging Markets Index
•
20 Feb 2018 22:09
EM Equity Strategy: Indonesia Perking Up; Overweight BRIC, Tech, and Health Care
Highlighted themes and actionable charts: Reiterating BRIC overweight. This country grouping continues to outperform broad EM, and we believe BRIC...
Vermilion Research
Follow
549 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x